Evolocumab Found Effective in Reducing Plasma LDL-C in Familial Hypercholesterolemia
Endocrinology Advisor,
Treatment with evolocumab was found to be effective in reducing plasma levels of low-density lipoprotein cholesterol (LDL-C) in…
Treatment with evolocumab was found to be effective in reducing plasma levels of low-density lipoprotein cholesterol (LDL-C) in…
In giovani pazienti con ipercolesterolemia familiare, la sicurezza dell'avvio di un trattamento con evolocumab stata confermata…
Safety of starting young patients with familial hypercholesterolemia on evolocumab (Repatha) was upheld by over 4 years of data…
Safety of starting young patients with familial hypercholesterolemia on evolocumab (Repatha) was upheld by over 4 years of data…